- Home
- PTCT vs CBZ Comparison
PTCT vs CBZ Comparison
Compare PTCT & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- CBZ
- Stock Information
- Founded
- PTCT 1998
- CBZ 1987
- Country
- PTCT United States
- CBZ United States
- Employees
- PTCT N/A
- CBZ N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- CBZ Business Services
- Sector
- PTCT Health Care
- CBZ Consumer Discretionary
- Exchange
- PTCT Nasdaq
- CBZ Nasdaq
- Market Cap
- PTCT 3.9B
- CBZ 4.2B
- IPO Year
- PTCT 2013
- CBZ N/A
- Fundamental
- Price
- PTCT $52.13
- CBZ $61.75
- Analyst Decision
- PTCT Buy
- CBZ Strong Buy
- Analyst Count
- PTCT 14
- CBZ 1
- Target Price
- PTCT $67.64
- CBZ $86.00
- AVG Volume (30 Days)
- PTCT 1.1M
- CBZ 678.8K
- Earning Date
- PTCT 08-07-2025
- CBZ 07-30-2025
- Dividend Yield
- PTCT N/A
- CBZ N/A
- EPS Growth
- PTCT N/A
- CBZ N/A
- EPS
- PTCT 7.51
- CBZ 1.84
- Revenue
- PTCT $1,772,758,000.00
- CBZ $2,420,673,000.00
- Revenue This Year
- PTCT $120.38
- CBZ $58.65
- Revenue Next Year
- PTCT N/A
- CBZ $5.74
- P/E Ratio
- PTCT $6.94
- CBZ $33.19
- Revenue Growth
- PTCT 91.12
- CBZ 46.49
- 52 Week Low
- PTCT $29.02
- CBZ $56.83
- 52 Week High
- PTCT $58.38
- CBZ $90.13
- Technical
- Relative Strength Index (RSI)
- PTCT 62.66
- CBZ 28.43
- Support Level
- PTCT $44.15
- CBZ $56.83
- Resistance Level
- PTCT $52.70
- CBZ $76.70
- Average True Range (ATR)
- PTCT 1.87
- CBZ 3.21
- MACD
- PTCT 0.59
- CBZ -1.34
- Stochastic Oscillator
- PTCT 93.33
- CBZ 23.32
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.